After active treatment, patients with invasive carcinoma of the uterine cervix can obtain a five-year survival rate of 10% to 80%, so there is a certain clinical cure rate. Cervical invasive carcinoma is a common malignant tumor of female reproductive system, and the occurrence of the disease is related to human papillomavirus infection, heredity and other factors. After diagnosis, the main treatment is surgical excision-based comprehensive treatment. After active treatment, the five-year survival rate of patients is highly related to the stage. Stage I patients have a five-year survival rate of about 80%; stage II, about 60%; stage III, about 20% to 30%; and stage IV, only 10%. In general, the earlier the stage, the better the prognosis. Attention to regular review after surgery can reduce recurrence and prolong survival to a certain extent. When invasive cervical cancer is present, it is necessary to actively consult the doctor and take reasonable treatment under the guidance of the doctor to prolong the survival period.